Kei Yamasaki Selected Research

Clarithromycin (Biaxin)

11/2017	The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.
1/2012	Two cases of primary ciliary dyskinesia with different responses to macrolide treatment.
1/2012	A case of Good syndrome with pulmonary lesions similar to diffuse panbronchiolitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kei Yamasaki Research Topics

Disease

22	Pneumonia (Pneumonitis) 08/2023 - 01/2011
7	Neoplasms (Cancer) 12/2023 - 09/2013
7	Lung Neoplasms (Lung Cancer) 11/2023 - 03/2014
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2011
5	Chronic Obstructive Pulmonary Disease (COPD) 10/2023 - 01/2018
5	Infections 11/2017 - 01/2011
4	Asthma (Bronchial Asthma) 10/2023 - 09/2014
4	Pleural Effusion (Pleural Effusions) 01/2022 - 01/2014
4	Respiratory Tract Infections (Respiratory Tract Infection) 12/2014 - 10/2011
3	Lymphoma (Lymphomas) 11/2023 - 09/2013
3	Adenocarcinoma 10/2023 - 07/2015
3	Respiratory Insufficiency (Respiratory Failure) 06/2022 - 01/2011
3	Empyema 01/2022 - 01/2014
3	Lung Diseases (Lung Disease) 01/2022 - 06/2011
3	Healthcare-Associated Pneumonia 05/2016 - 10/2013
2	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2020
2	Bacterial Pneumonia 04/2022 - 04/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 08/2014
2	Dyspnea (Shortness of Breath) 01/2022 - 11/2008
2	Tuberculosis (Tuberculoses) 01/2022 - 06/2014
2	Idiopathic Interstitial Pneumonias 01/2022 - 09/2011
2	Rheumatoid Arthritis 01/2022 - 11/2008
2	Invasive Pulmonary Aspergillosis 07/2021 - 10/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2021 - 11/2020
2	Idiopathic Pulmonary Fibrosis 03/2021 - 08/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2011
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2011
2	Coinfection 12/2020 - 10/2011
2	Human Influenza (Influenza) 11/2017 - 01/2011
1	Coma (Comas) 01/2024
1	Neutropenia 01/2024
1	Bronchitis 12/2023
1	Pulmonary Atelectasis 12/2023
1	Chronic Renal Insufficiency 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2023
1	Eosinophilia 10/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	COVID-19 03/2023
1	Disease Progression 03/2023
1	Adenocarcinoma of Lung 01/2023
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023
1	Pulmonary Embolism 04/2022
1	Pleurisy (Pleuritis) 01/2022
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022

Drug/Important Bio-Agent (IBA)

13	16S Ribosomal RNAIBA 10/2022 - 01/2011
12	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 01/2011
4	AntibodiesIBA 01/2024 - 10/2011
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 02/2014
4	Prednisolone (Predate)FDA LinkGeneric 01/2019 - 09/2011
3	Immune Checkpoint InhibitorsIBA 10/2023 - 11/2020
3	Immunosuppressive Agents (Immunosuppressants)IBA 06/2022 - 09/2015
3	Oxygen (Dioxygen)IBA 08/2019 - 01/2011
3	Clarithromycin (Biaxin)FDA LinkGeneric 11/2017 - 01/2012
3	Azithromycin (Zithromax)FDA LinkGeneric 06/2014 - 01/2012
2	Phosphotransferases (Kinase)IBA 11/2023 - 08/2019
2	Tyrosine Kinase InhibitorsIBA 11/2023 - 10/2023
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023 - 08/2014
2	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 01/2018
2	CollagenIBA 01/2022 - 07/2015
2	AsbestosIBA 01/2022 - 01/2017
2	liposomal amphotericin B FDA Link 07/2021 - 10/2011
2	Carboplatin (JM8)FDA LinkGeneric 05/2021 - 03/2014
2	NivolumabIBA 01/2021 - 11/2020
2	Doripenem FDA Link 06/2019 - 03/2016
2	AntigensIBA 03/2015 - 01/2011
1	Praziquantel (Biltricide)FDA Link 01/2024
1	Celecoxib (Celebrex)FDA Link 12/2023
1	PlasticsIBA 12/2023
1	alectinibIBA 11/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2023
1	Anaplastic Lymphoma KinaseIBA 11/2023
1	CrizotinibIBA 11/2023
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	osimertinibIBA 10/2023
1	kakkon-toIBA 08/2023
1	nafamostatIBA 03/2023
1	favipiravirIBA 03/2023
1	GSK573719IBA 01/2023
1	vilanterolIBA 01/2023
1	anti-amphiphysin autoantibodyIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	fluticasone furoate FDA Link 01/2023
1	durvalumabIBA 01/2023
1	Muscarinic AntagonistsIBA 01/2023
1	AnticoagulantsIBA 04/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Organic Chemicals (Chemicals, Organic)IBA 01/2022
1	Local AnestheticsIBA 01/2022
1	Amikacin (A.M.K)FDA LinkGeneric 01/2022
1	Serpentine Asbestos (Chrysotile)IBA 01/2022
1	avelumabIBA 01/2022
1	carbopol 940 (sodium polyacrylate)IBA 01/2022

Therapy/Procedure

12	Therapeutics 10/2023 - 09/2011
4	Drug Therapy (Chemotherapy) 01/2022 - 03/2014
2	Length of Stay 01/2024 - 01/2022
2	Thoracotomy 01/2024 - 01/2022
2	Bronchoscopes 12/2023 - 01/2019
2	Nebulizers and Vaporizers (Inhaler) 01/2023 - 09/2014
1	Chemoradiotherapy 01/2023